[fcb5af]: / literature / by_gene / HLA-C.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 30155344 10.1186/s40164-018-0112-y 2022 The association of HLA-C alleles with multiple myeloma in Chinese patients. HLA-C
2 35114151 10.1016/S2352-3026(21)00369-0 2022 KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. HLA-C
3 35358442 10.1016/S2352-3026(22)00036-9 2022 In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial. HLA-C
4 31428523 10.1080/2162402X.2019.1625688 2021 NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma. HLA-C
5 31704471 10.1016/j.bbmt.2019.10.032 2021 Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study. HLA-C
6 32883310 10.1186/s12977-020-00536-y 2021 HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina. HLA-C
7 33622167 10.1080/10428194.2021.1885655 2021 Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates. HLA-C
8 30715139 10.1093/asj/sjz021 2020 Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. HLA-C
9 30871628 10.1186/s40425-019-0538-8 2020 Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab. HLA-C
10 31958417 10.1016/S2352-3026(19)30220-0 2020 Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial. HLA-C
11 29197675 10.1016/j.bbmt.2017.11.029 2019 Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. HLA-C
12 30001986 10.1016/j.clml.2018.06.011 2019 A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome. HLA-C
13 26527563 10.1111/bjh.13777 2018 Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia. HLA-C
14 27090957 10.1016/j.bbmt.2016.04.007 2018 Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia. HLA-C
15 27273744 10.1111/tan.12829 2018 The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients. HLA-C
16 28722359 10.1111/tan.13087 2018 A novel allele, HLA-C*14:02:01:03, identified by full-length genomic sequencing. HLA-C
17 27414060 10.1111/cei.12842 2017 Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. HLA-C
18 26472014 10.1016/j.humimm.2015.10.009 2016 Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. HLA-C
19 24533560 10.1111/jdv.12391 2015 Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients. HLA-C
20 25515183 10.1111/tan.12485 2015 The full length genomic sequence of a novel HLA-C*03 allele: HLA-C*03:219. HLA-C
21 25627829 10.1007/s10875-014-0125-1 2015 Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation. HLA-C
22 25802187 10.1002/hep.27794 2015 Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. HLA-C
23 24131084 10.1111/tan.12208 2014 Novel HLA-C*07:314 allele identified by sequence-based typing in a French lymphoblastic leukemia patient. HLA-C
24 25163702 10.1182/blood-2014-05-572065 2014 KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse. HLA-C
25 22676066 10.3109/08820139.2012.691148 2013 HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer Cells. HLA-C
26 22923051 10.1007/s00251-012-0648-7 2013 The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation. HLA-C
27 23843497 10.1182/blood-2013-02-483420 2013 HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma. HLA-C
28 24043749 10.1200/JCO.2012.47.4007 2013 Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation. HLA-C
29 21982422 10.1016/S1470-2045(11)70260-1 2012 Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. HLA-C
30 22035606 10.1111/j.1399-0039.2011.01778.x 2012 Characterization of the novel HLA-C*16:07:02 allele in a family of Benin origin. HLA-C
31 22340965 10.1016/S1470-2045(12)70004-9 2012 Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. HLA-C
32 20870028 10.1016/j.bbmt.2010.09.012 2011 HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. HLA-C
33 21059899 10.1182/blood-2010-08-301598 2011 MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia. HLA-C
34 21067287 10.3109/08916930903567492 2011 Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk. HLA-C
35 21299541 10.1111/j.1399-0039.2010.01610.x 2011 HLA-C*03:93, a novel HLA-C*03 allele identified by sequence-based typing. HLA-C
36 20056126 10.1016/j.exphem.2009.12.007 2010 B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression. HLA-C
37 20196822 10.1111/j.1399-0039.2009.01398.x 2010 Identification of the novel allele Cw*040110 in a German patient. HLA-C
38 20385791 10.1182/blood-2010-01-266775 2010 Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. HLA-C
39 20558104 10.1016/S1470-2045(10)70127-3 2010 Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. HLA-C
40 18544086 10.1111/j.1365-2141.2008.07177.x 2009 Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. HLA-C
41 18841361 10.1007/s00262-008-0601-7 2009 Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells. HLA-C
42 19363276 2009 Posttransplant malignancies and their relationship with human leukocyte antigens in kidney allograft recipients. HLA-C
43 19493232 10.1111/j.1399-0039.2009.01235.x 2009 Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. HLA-C
44 19620980 10.1038/ng.419 2009 Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. HLA-C
45 17971052 10.1111/j.1399-0039.2007.00954.x 2008 Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. HLA-C
46 18005680 10.1016/j.chom.2007.01.001 2008 A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. HLA-C
47 18301962 10.1007/s12185-008-0040-4 2008 Association of HLA alleles with non-Hodgkin's lymphoma in Korean population. HLA-C
48 17145860 10.1158/0008-5472.CAN-06-2326 2007 Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. HLA-C
49 17302780 10.1111/j.1537-2995.2007.01109.x 2007 A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. HLA-C
50 17311253 10.1002/gcc.20436 2007 Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma. HLA-C
51 17560447 10.1016/S0140-6736(07)60915-5 2007 Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. HLA-C
52 17909631 10.1172/JCI32377 2007 HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. HLA-C
53 15731175 10.1182/blood-2004-12-4825 2005 Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. HLA-C
54 14727382 2004 [Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela]. HLA-C
55 12688350 10.1080/1042819021000035707 2003 Association of familial leukemia with HLA Cw3: is it real? HLA-C
56 14515258 10.1002/eji.200324182 2003 Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. HLA-C
57 12010826 10.1182/blood.v99.11.4200 2002 The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. HLA-C
58 12060128 10.1046/j.1365-2141.2002.03504.x 2002 Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation. HLA-C
59 12148880 10.1080/10428190290021588 2002 Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia. HLA-C
60 10715516 10.1016/s0198-8859(99)00186-x 2000 Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. HLA-C
61 10717799 10.1016/s0198-8859(99)00147-0 2000 Unrelated donors selected prospectively by block-matching have superior bone marrow transplant outcome. HLA-C
62 10498594 1999 Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. HLA-C
63 9753057 10.1046/j.1365-2141.1998.00919.x 1998 Lack of association between childhood common acute lymphoblastic leukaemia and an HLA-C locus dimorphism influencing the specificity of natural killer cells. HLA-C
64 9780337 10.1056/NEJM199810223391701 1998 Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. HLA-C
65 7761977 10.1111/j.1399-0039.1995.tb02437.x 1995 The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. HLA-C
66 1326579 1992 Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides. HLA-C
67 1655115 1991 Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines. HLA-C
68 1899854 10.1002/ijc.2910470412 1991 Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. HLA-C
69 2395381 1990 Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies. HLA-C
70 2804917 10.1002/1097-0142(19891201)64:11<2259::aid-cncr2820641113>3.0.co;2-0 1989 Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid. HLA-C
71 3209056 10.1002/gepi.1370050609 1989 Significant association of acute lymphoblastic leukemia with HLA-Cw7. HLA-C
72 2450918 1988 Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin. HLA-C
73 3131426 1988 Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene. HLA-C
74 3164632 10.1111/j.1365-2141.1988.tb07626.x 1988 More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3. HLA-C
75 2423453 10.3109/08820138609042018 1986 Study on the association of HLA with malignant lymphoma. HLA-C
76 2578520 1985 Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens. HLA-C
77 3872893 10.1016/s0190-9622(85)70075-8 1985 Human leukocyte antigens in cutaneous T cell lymphoma. HLA-C
78 6303316 10.1042/bj2100079 1983 Human class I histocompatibility antigens (HLA-A,B,C). A small proportion only is phosphorylated. HLA-C
79 6960462 1983 [Detection of HLA-A, B and C antigens on various normal and pathologic cells using the monoclonal antibody W6/32]. HLA-C
80 6181407 1982 Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines. HLA-C
81 6951167 10.1073/pnas.79.4.1190 1982 Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression. HLA-C